Alloporinol, chamomile and normal saline mouthwashes for the prevention of chemotherapy-induced stomatitis

Journal of Clinical and Diagnostic Research

Volumn 3, Issue 3, 2009, Pages 1537-1542

  Shabanloei, Reza ^a   Ahmadi, F ^b   Vaez, J ^a   Ansarin, K ^c   Hajizadeh, E ^b   Javadzadeh, Y ^d   Dolathkhah, R ^a   Gholchin, M ^e  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c Department of Internal Medicine   (Iran)

^d Faculty of Pharmacy   (Iran)

^e Faculty of Pharmacy ^*

Author keywords

Alloporinol; Chamomile; Chemotherapy; Mouthwash; Stomatitis

Indexed keywords

ALLOPURINOL; ANTINEOPLASTIC AGENT; CHAMOMILE; MOUTHWASH; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUTH PAIN; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; STOMATITIS;

EID: 67650105682     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sonis ST. Oral Mucositis in Cancer Therapy. The Journal Support Oncology 2004; 2(3):3-8.
2. Eilers. J, Million R. Prevention and management of oral mucositis in patients with cancer. Semin Oncol Nurs. 2007; Aug 23(3):201-12. Review
3. Cheng KK, Chang AM, Yuen MP. Prevention of oral mucositis in paediatric patients treated with Chemotherapy: a randomized crossover trial comparing two Protocols of oral care. Euro J of Cancer 2004; May 40(8): 1208-16.
4. Giles F J, Rodriguez R, Weisdorf D, Wingard JR, Martin PJ, Fleming TR. A Phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. Leuk Res 2004; Jun 28(6): 559-65.
5. Gerpen RV. An Overview of Oral Mucositis. Oncology Supportive Care Quarterly 2005;,3(2):4-10.
6. Sonis ST. Pathobiology of oral Mucositis: Novel insights and Opportunities. J Support Oncol. 2007; Oct 5(9 Suppl 4):3-11.
7. Brown CG, Wingard J. Clinical consequences of oral mucositis. Semin Oncol Nurs. 2004; Feb 20(1): 16-21.
8. Bruce S. Pain Management Issues and Strategies in Oral Mucositis. Oncology Supportive Care Quarterly.2004; 3(2):18-27.
9. Epstein JB, Schubert MM. Managing pain in mucositis. Semin Oncol Nurs 2004; Feb, 20(1):30-37.
10. Spielberger R.T. Kepivance: A Breakthrough for Oral Mucositis Associated with Myeloablative Hematopoietic Stem tem Cell Transplant. Center for International Blood and Marrow Transplant Research (CIMBTR) 2005; 11(1):2-13.
11. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004; May 100(9):1995-2025.
12. Dorothy M, Stephen T. Joanne M. Emerging drugs for chemotherapy-induced Mucositis. Expert Opinion on Emerging Drugs 2008;13(3):511-22.
13. Sonis ST. Pathobiology of Oral Mucositis: novel insights and opportunities. J Support Oncol. 2007; Oct 5(9 Suppl 4):3-11. Review.
14. Lalla RV, Sonis ST, Peterson DE. Management of Oral Mucositis in Patients who have cancer. Dent Clin North Am 2008; Jan 52(1):61-77.
15. Massacesi C. Cancer therapy-induced oral mucositis: a comprehensive review. Continuing Education in Oncologia 2005; II (1):1-12.
16. Armenta S, Esteve-Turrillas F. A, Quintás G, Garrigues S, Pastor A, and et al. Development of a simple and low cost device for vapour phase Fourier Transform Infrared spectrometry determination of ethanol in mouthwashes. Analytica Chimica Acta.2006;569(1):238-43.
17. Wang Y, Tang H, Nicholson JK, Hylands PJ, Sampson J , Holmes E. A Metabonomic Strategy for the Detection of the Metabolic Effects of Chamomile (Matricaria recutita L.) J Agric Food Chem. 2005; Jan 26, 53(2):191-6
18. Szoke E, Maday E, Tyihak E, Kuzovkina N, Lemberkovics E. New terpenoids in cultivated and wild chamomile (in vivo and in vitro). J Chromatogr B Analyt Technol Biomed Life Sci. 2004; Feb 800(1-2):231-8
19. Eilers J, Epstein JB. Assessment and Measurement of Oral Mucositis. Semin Oncol Nurs. 2004; Feb 20(1): 22-29
20. Eilers J, Million R. Prevention and Management of oral Mucositis in patients with cancer. Semin Oncol Nurs. 2007; Aug 23(3): 201-12.
21. Avritscher EB, Cooksley CD, Elting LS. Scope and Epidemiology of Cancer Therapy-Induced Oral and Gastrointestinal Mucositis. Semin Oncol Nurs 2004; Feb 20(1):3-10.
22. Blohmer JU, Dunst J, Harrison L, Johnston P, Khavat D, Ludwig H et al. Cancer-related anemia: biological findings, clinical implications and impact on quality of life. Oncology. 2005; 68(1):12-21.
23. Eilers J. Nursing Interventions and Supportive Care for the Prevention and Treatment of Oral Mucositis Associated With Cancer Treatment. Oncol Nurs Forum. 2004; Jul 31(4):13-23.
24. Clark PI, Slevin ML. Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity. Eur J Surg Oncol. 1985; Sep11(3):267-68
25. Loprinzi CL, Cianflone SG, Dose AM, Ezell PS, Burnham NL, Therneau TM et al. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer 1990; Apr 65(8):1879-82.
26. Ito A, Hanawa T, Fujii E. The preventive effect of allopurinol spray on stomatitis induced by anti-cancer drugs. Gan To Kagaku Ryoho. 2002; Apr 29(4):563-7. Links
27. Vokurka S, Bystricka E, Koza V, Scudlova J, Pavlicova V, Valentova D et al. The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT - results of a randomized multicenter study. Supportive Care in Cancer 2005; Jul 13(7):554-8.